Fantastic experience - I met moomoo in NYC!
It looks cool.
Bullish! To the moon!![]()
![]()
![]()
![]()
![]()
![]()
It looks cool.
Bullish! To the moon!
5
1
Upside:
$Apple (AAPL.US)$ break over 235.7, 240c Dec 20--to target: $237
$Costco (COST.US)$ Break over 975, 1000c Dec 6--to target: $980
$Upstart (UPST.US)$ break over 80.77, 85c Dec 20--to target: $83
$DraftKings (DKNG.US)$ break over 43.48, 45c Dec 20--to target: $44.5
Downside:
$NVIDIA (NVDA.US)$ Break under 135.5, 132p Dec 6--to target: $134
$Apple (AAPL.US)$ break over 235.7, 240c Dec 20--to target: $237
$Costco (COST.US)$ Break over 975, 1000c Dec 6--to target: $980
$Upstart (UPST.US)$ break over 80.77, 85c Dec 20--to target: $83
$DraftKings (DKNG.US)$ break over 43.48, 45c Dec 20--to target: $44.5
Downside:
$NVIDIA (NVDA.US)$ Break under 135.5, 132p Dec 6--to target: $134
7
Prediction markets now show Kamala Harris with a 3 percentage point lead on Donald Trump, according to Polymarket's prediction app.
All signs point to an incredibly close race with the election now 5 weeks out.
$Trump Media & Technology (DJT.US)$ $Kamala Harris (LIST22990.US)$ $Donald Trump (LIST22962.US)$
All signs point to an incredibly close race with the election now 5 weeks out.
$Trump Media & Technology (DJT.US)$ $Kamala Harris (LIST22990.US)$ $Donald Trump (LIST22962.US)$
2
7
While I personally prefer buying $Micron Technology (MU.US)$ near book value (where it was merely a year ago), there are worse things than an oligopolistic growth cyclical delivering to an end-market in a boom phase
3
1
The chart below displays some (but not all) of the key components used in calculating return on capital including the free cash flow (grey bars), property plant & equipment (green line) and goodwill (red line).
We are focusing only on these three because I would like to highlight a key question: will all of the recent capital investment pay off?
During the early 2000s, FCF regularly exceeded PPE an...
We are focusing only on these three because I would like to highlight a key question: will all of the recent capital investment pay off?
During the early 2000s, FCF regularly exceeded PPE an...
12
Charlie Kawwas head of $Broadcom (AVGO.US)$ semis business was even more explicit and detailed on this today at GS, segmenting the AI accelerator mkt into three parts:
- Internet scale customers ( $Meta Platforms (META.US)$ $Alphabet-C (GOOG.US)$ Bytedance Tencent): significant logic and value for these companies spending $10s of Bns all on internal infra to customize ASICs for own environments. AVGO can bring new XPUs to mkt in a year. Sees most of this mkt going to custom silicon in 5yrs.
- Hyperscale...
- Internet scale customers ( $Meta Platforms (META.US)$ $Alphabet-C (GOOG.US)$ Bytedance Tencent): significant logic and value for these companies spending $10s of Bns all on internal infra to customize ASICs for own environments. AVGO can bring new XPUs to mkt in a year. Sees most of this mkt going to custom silicon in 5yrs.
- Hyperscale...
3
3
$NVIDIA (NVDA.US)$ REPORTS ON WEDNESDAY
ARE WE BULLISH OR BULLISH
....or bearish
I think they beat the $28B guide and raise. The big question here is on the raise because of the Blackwell delay but given $Super Micro Computer (SMCI.US)$ guidance and $Taiwan Semiconductor (TSM.US)$ monthly metrics, I don't think that will have the largest impact for Q3.
All eyes on Jensen.
ARE WE BULLISH OR BULLISH
....or bearish
I think they beat the $28B guide and raise. The big question here is on the raise because of the Blackwell delay but given $Super Micro Computer (SMCI.US)$ guidance and $Taiwan Semiconductor (TSM.US)$ monthly metrics, I don't think that will have the largest impact for Q3.
All eyes on Jensen.
5
1
Argument:
The upcoming interest rate cuts are poised to benefit the biotech stock industry, setting the stage for strong performance in the coming quarters.
Reasons:
Cheaper Funding: Lower interest rates make it easier for biotech companies to access capital for research and development, accelerating their progress and growth potential.
Attractive Valuations: Biotech stocks are currently trading at attractive levels, offering investors an opportunity to capitalize on the sector's long-term pot...
The upcoming interest rate cuts are poised to benefit the biotech stock industry, setting the stage for strong performance in the coming quarters.
Reasons:
Cheaper Funding: Lower interest rates make it easier for biotech companies to access capital for research and development, accelerating their progress and growth potential.
Attractive Valuations: Biotech stocks are currently trading at attractive levels, offering investors an opportunity to capitalize on the sector's long-term pot...
5
1
1
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)